Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm D Mason

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology|August 27, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate CancerAlex P Hoyle, Adnan Ali, Nicholas D James, et al.
European Urology|April 15, 2017
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic BiologySteven M Walker, Laura A Knight, Andrena M McCavigan, et al.
BJU International|April 4, 2022
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)Janet Athene Lane, Jenny L Donovan, Grace J Young, et al.
ESMO Open|September 21, 2018
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine ProgrammeColin R Lindsay, Emily C Shaw, Fiona Blackhall, et al.
European Urology|November 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|October 22, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewThomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, et al.
European Urology|October 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate CancerPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2017
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled TrialMalcolm D Mason, Noel W Clarke, Nicholas D James, et al.
European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology|August 27, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate CancerAlex P Hoyle, Adnan Ali, Nicholas D James, et al.
European Urology|April 15, 2017
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic BiologySteven M Walker, Laura A Knight, Andrena M McCavigan, et al.
BJU International|April 4, 2022
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)Janet Athene Lane, Jenny L Donovan, Grace J Young, et al.
ESMO Open|September 21, 2018
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine ProgrammeColin R Lindsay, Emily C Shaw, Fiona Blackhall, et al.
European Urology|November 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|October 22, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewThomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, et al.
European Urology|October 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate CancerPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2017
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled TrialMalcolm D Mason, Noel W Clarke, Nicholas D James, et al.
European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
Pageof 15